Preferential volume reduction of diseased segments of a heterogeneous lobe

• US 9,782,211 B2
• Filed: 10/01/2014
• Issued: 10/10/2017
• Est. Priority Date: 10/01/2013
• Status: Active Grant

• Current Assignee: Uptake Medical Technology Inc.
• Original Assignee: Uptake Medical Technology Inc.
• Inventors: Barry, Robert Lawrence, Henne, Erik, Gupta, Avina, Bandyopadhyay, Sourish
• Primary Examiner(s): Jang, Christian
• Assistant Examiner(s): Alter, Mitchell E
• Application Number:
  US14/504,042
• Publication Number:
  US 20150094607A1
• Time in Patent Office: 1,105 Days
• Field of Search: 600538, 604 26
• CPC Class Codes: A61B 18/04 by heating by applying electromagnetic radiation A61B18/18; hyperthermia using electric or magnetic fields, radiation or ultrasound A61N
• CPC Class Codes: A61B 2018/00285 Balloons
• CPC Class Codes: A61B 2018/00541 Lung or bronchi
• CPC Class Codes: A61B 2018/048 in gaseous form
• CPC Class Codes: A61B 2034/105 Modelling of the patient, e.g. for ligaments or bones
• CPC Class Codes: A61B 34/10 Computer-aided planning, simulation or modelling of surgical operations
• CPC Class Codes: A61B 5/08 Detecting, measuring or recording devices for evaluating the respiratory organs A61B5/0205 takes precedence

Abstract

Methods and apparatus for diagnosing and treating disorders of the lung are provided, which may include any number of features. In one embodiment, a method comprises obtaining diagnostic information relating to a patient'"'"'s lungs, compiling a list of potential treatment plans for lung volume reduction in the first and second lungs, excluding treatment plans from the list of potential treatment plans that propose treatment of a lung segment that falls within a segment exclusion rule, and identifying at least one preferred treatment plan from the list of potential treatment plans that targets sufficiently diseased lung segments while also targeting a preferred combined volume of the first and second lungs.

Claims

1. A computer-implemented method of treatment planning for assisting a physician perform bronchoscopic lung volume reduction, comprising:

obtaining diagnostic information including information derived from images relating to a patient'"'"'s first and second lungs;

compiling, automatically on a processor or electronic controller, a plurality of potential lung segment combinations for lung volume reduction in the first and second lungs wherein each potential lung segment combination includes at least one lung segment from the first lung and at least one lung segment from the second lung;

computing, automatically on the processor or electronic controller, a plurality of diagnostic values for each lung segment of said potential lung segment combinations;

determining a segment exclusion rule operable to exclude one or more of the potential lung segment combinations based on comparing the diagnostic value from the computing step to a threshold value or range;

excluding, automatically on the processor or electronic controller, at least one of the potential lung segment combinations based on said segment exclusion rule; and

identifying, automatically on the processor or electronic controller, at least one preferred segment combination not excluded from the potential lung segment combinations for the bronchoscopic lung volume reduction, wherein the preferred segment combination targets diseased lung segments while also targeting a preferred combined volume of the first and second lungs based on the diagnostic values from the computing step.

2. The method of claim 1 wherein the diagnostic values are selected from the group consisting of a tissue-to-air ratio, a heterogeneity index, an air volume, a mass, and a percentage of a lobe of each segment of the first and second lungs.

3. The method of claim 1 wherein compiling comprises compiling a list of potential treatments that include a first treatment that targets a first segment of a first lobe of the first lung, and a second treatment that targets a second segment of a second lobe of the second lung.

4. The method of claim 3 wherein the second treatment also targets a third segment of the second lobe of the second lung.

5. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations including lung segments that have a heterogeneity index under 1.2 be excluded.

6. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations including lung segments that have a mass less than 13 g be excluded.

7. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations including segments having a tissue mass in grams plus air volume in milliliters greater than 1700 be excluded.

8. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations segments that have a mass greater than 48 g be excluded.

9. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations including treatment of the first lung that treats less than 30% of the volume of the first lung or more than 70% of the volume of the first lung be excluded.

10. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations including treatment of the second lung that treats less than 40% of the volume of the second lobe or more than 80% of the volume of the second lobe be excluded.

11. The method of claim 1 wherein the segment exclusion rule requires that lung segment combinations including a treatment of the first and second lungs resulting in less than 95% or greater than 130% of a combined percentage of volume of the first and second lungs be excluded.

12. The method of claim 1 wherein the at least one preferred lung segment combination requires treatment of segments with an insignificant difference in tissue-to-air ratios (TARs).

13. The method of claim 12 wherein the insignificant difference comprises a difference of less than 2% between the TARs of the lung segments of the lung segment combination.

14. The method of claim 12 wherein the at least one preferred segment combination requires treatment of lung segments that rank closest to 110% of a combined percentage of the first and second lungs to be treated.

15. The method of claim 1, wherein the at least one preferred segment combination comprises applying lung volume reduction therapy to at least one lung segment in the first lung and at least one lung segment in the second lung.

16. The method of claim 15 wherein the lung volume reduction therapy comprises delivering condensable vapor to the patient'"'"'s lungs.

17. The method of claim 1 wherein the compiling step comprises compiling a list potential segment combinations in a ranked order.

18. The method of claim 17 further comprising displaying the list.